Schedule 13D ownership disclosure
TRINITY BIOTECH INVT LTD
Class 'A' Ordinary Shares · CUSIP: 896438504
Event date: 2025-12-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- DAYLI Partners, Inc.Reported CIK 0002101262
Shares: 0 · Class: 0.0%
- DAYLI TRINITY HOLDINGS, Ltd.
Shares: 0 · Class: 0.0%
- DAYLI Fountainhead Project No.3 Private Equity Fund
Shares: 0 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-319692
- Form type
- SCHEDULE 13D/A
- Filer
- DAYLI Partners, Inc.
- CIK
- CIK 2101262
- Filed
- Dec 15, 2025
- Reporting period
- Dec 02, 2025
- Description
- Schedule 13D beneficial ownership